Scopus BioPharma (SCPS) Competitors

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

$0.0011

0.00 (0.00%)

(As of 05/14/2024 ET)

Stock Analysis Chart Competitors Financials Insider Trades SEC Filings Social Media

SCPS vs. STAB, NOVNQ, CALA, OBSV, IGNY, HGEN, AHPI, ONCSQ, CNTX, and GRFS

Should you be buying Scopus BioPharma stock or one of its competitors? The main competitors of Scopus BioPharma include Statera Biopharma (STAB), NVN Liquidation (NOVNQ), Calithera Biosciences (CALA), ObsEva (OBSV), Ignyte Acquisition (IGNY), Humanigen (HGEN), Allied Healthcare Products (AHPI), OncoSec Medical (ONCSQ), Context Therapeutics (CNTX), and Grifols (GRFS). These companies are all part of the "medical" sector.

Scopus BioPharma vs.

Scopus BioPharma (NASDAQ:SCPS) and Statera Biopharma (NASDAQ:STAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, community ranking, dividends and earnings.

: Scopus BioPharma has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500. Comparatively, Statera Biopharma has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scopus BioPharma
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Statera Biopharma
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, Statera Biopharma had 1 more articles in the media than Scopus BioPharma. MarketBeat recorded 1 mentions for Statera Biopharma and 0 mentions for Scopus BioPharma. Scopus BioPharma's average media sentiment score of 0.00 beat Statera Biopharma's score of -1.57 indicating that Scopus BioPharma is being referred to more favorably in the media.
Company Overall Sentiment
Scopus BioPharma Neutral
Statera Biopharma Very Negative
: Company Net Margins Return on Equity Return on Assets
Scopus BioPharma N/A N/A N/A
Statera Biopharma N/A N/A N/A
: Scopus BioPharma has higher earnings, but lower revenue than Statera Biopharma.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Scopus BioPharma N/A N/A -$11.61M N/A N/A
Statera Biopharma $1.49M 0.03 -$101.85M N/A N/A
: Scopus BioPharma received 2 more outperform votes than Statera Biopharma when rated by MarketBeat users.
Company Underperform Outperform
Scopus BioPharma Outperform Votes
2
100.00%
Underperform Votes
No Votes
Statera Biopharma N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scopus BioPharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Statera Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
Scopus BioPharma	Neutral
Statera Biopharma	Very Negative

Company	Net Margins	Return on Equity	Return on Assets
Scopus BioPharma	N/A	N/A	N/A
Statera Biopharma	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scopus BioPharma	N/A	N/A	-$11.61M	N/A	N/A
Statera Biopharma	$1.49M	0.03	-$101.85M	N/A	N/A

Company	Underperform	Outperform
Scopus BioPharma	Outperform Votes 2 100.00%	Underperform Votes No Votes
Statera Biopharma	N/A	N/A

Summary

Scopus BioPharma and Statera Biopharma tied by winning 3 of the 6 factors compared between the two stocks.

Ad Crypto 101 Media

The Crypto 9-5 Escape Plan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

Get Scopus BioPharma News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCPS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

SCPS vs. The Competition

Export to Excel

Metric	Scopus BioPharma	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$46,000.00	$6.61B	$5.01B	$7.86B
Dividend Yield	N/A	2.76%	39.55%	3.93%
P/E Ratio	N/A	19.86	171.16	17.80
Price / Sales	N/A	287.34	2,382.88	81.64
Price / Cash	N/A	20.56	33.06	28.46
Price / Book	0.00	5.95	5.02	4.48
Net Income	-$11.61M	$137.03M	$104.25M	$216.51M
7 Day Performance	N/A	-1.09%	0.07%	1.56%
1 Month Performance	N/A	-2.63%	-0.26%	1.86%
1 Year Performance	N/A	-0.83%	5.79%	11.14%

Scopus BioPharma Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAB Statera Biopharma	0 of 5 stars	$0.00 flat	N/A	-96.4%	$38,000.00	$1.49M	0.00	46	Upcoming Earnings High Trading Volume
NOVNQ NVN Liquidation	0 of 5 stars	N/A	N/A	N/A	$22,000.00	$23.68M	0.00	90	Gap Up
CALA Calithera Biosciences	0 of 5 stars	$0.02 flat	N/A	-23.4%	$97,000.00	$9.75M	0.00	8
OBSV ObsEva	0 of 5 stars	$0.00 flat	N/A	N/A	$156,000.00	$20.11M	0.00	48	Analyst Forecast News Coverage Gap Down
IGNY Ignyte Acquisition	0 of 5 stars	$0.01 flat	N/A	-98.9%	$63,000.00	N/A	0.00	N/A
HGEN Humanigen	0 of 5 stars	$0.00 flat	N/A	N/A	$24,000.00	$1.70M	0.00	6	Gap Down
AHPI Allied Healthcare Products	0 of 5 stars	N/A	N/A	N/A	$16,000.00	$27.05M	0.00	189	Analyst Forecast News Coverage
ONCSQ OncoSec Medical	0 of 5 stars	$0.00 flat	N/A	N/A	$2,000.00	N/A	0.00	40
CNTX Context Therapeutics	2.791 of 5 stars	$1.72 -3.4%	$4.00 +132.6%	+201.8%	$0.00	N/A	-1.15	5	News Coverage
GRFS Grifols	3.3469 of 5 stars	$6.80 -3.1%	$10.50 +54.4%	-16.6%	$0.00	$7.13B	0.00	23,737	News Coverage

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:SCPS) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Scopus BioPharma (SCPS) Competitors

SCPS vs. STAB, NOVNQ, CALA, OBSV, IGNY, HGEN, AHPI, ONCSQ, CNTX, and GRFS

Scopus BioPharma vs.

Summary

New MarketBeat Followers Over Time

SCPS vs. The Competition

Scopus BioPharma Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info